| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,910 | $40 | $68.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $100 | $31.3K |
| J0897 | Injection, denosumab, 1 mg | 1,620 | $20 | $29.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 24,750 | $1 | $24.8K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,290 | $10 | $13.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 60 | $110 | $6.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 100 | $60 | $5.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 750 | $10 | $4.5K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 60 | $70 | $4.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $140 | $4K |